Evidence map›Paper›PMID 33255508›Full record

ReviewInternational journal of molecular sciences2020

WWOX Loss of Function in Neurodevelopmental and Neurodegenerative Disorders.

C Marcelo Aldaz, Tabish Hussain

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. B-cell-specificBlood neoplasia · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DNA Damage and Parkinson's Disease.International journal of molecular sciences · 2024
    Review
  13. Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C Marcelo AldazDepartment of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA.ORCID 0000-0002-2453-2939
Tabish HussainDepartment of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA.ORCID 0000-0001-5790-6776
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Genetic Predisposition to DiseaseAnimalsCentral Nervous SystemGerm-Line MutationHumansLoss of Function MutationMiceNeurodegenerative DiseasesNeurodevelopmental DisordersTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, humanADHDAlzheimer’s diseaseautismepileptic encephalopathyintellectual disabilitymultiple sclerosisneurodegenerationspinocerebellar ataxiaWOREEWWOX

Identifiers

PMID33255508
PMCPMC7727818
OpenAlexW3107485559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.